- Research
- Open access
- Published:
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pedis vein
Thrombosis Journal volume 23, Article number: 13 (2025)
Abstract
Objective
To evaluate the comparative effectiveness of two distinct balloon pressure band compression regimens on the treatment outcomes for deep vein thrombosis (DVT) and venous blood flow velocity in the lower limbs of patients undergoing anterograde thrombolysis through the superficial dorsalis pedis vein.
Methods
A total of 42 patients diagnosed with DVT were enrolled in the randomized controlled trial. Patients in the control group received balloon pressure band compression positioned 15 cm above the bony landmark of the medial malleolus of the affected limb, with continuous inflation and deflation. On the basis of the control group, a balloon pressure band was also used 15 cm above the bony landmark of the medial malleolus and 10 cm below the midpoint of the patella in the affected limb in experimental group, with rotational inflation at these two sites. The thrombolysis effects and venous blood flow velocity of the lower extremities were compared between the two groups.
Results
The differences in limb circumference and Marder scores of patients in the experimental group were significantly lower than those in the control group, while the detumescence rate and venous patency rate of the affected limbs in the experimental group were significantly higher than those in the control group (P < 0.05). After 30 and 60 min of thrombolysis, femoral and popliteal vein blood flow velocities in the experimental group were significantly higher than those in the control group (P < 0.05). After 45 min post-thrombolysis, the femoral vein blood flow velocity in the experimental group remained significantly higher than that in the control group (P < 0.05), though no significant difference was observed in the popliteal vein blood flow velocity (P > 0.05).
Conclusion
In this study, alternating balloon pressure band compression applied at 15 cm above the bony marker of the medial malleolus and 10 cm below the patellar midpoint to block superficial venous blood flow was found to enhance thrombolysis efficacy and significantly improve venous blood flow velocity in the lower extremities among patients with DVT.
Introduction
Deep vein thrombosis (DVT) is characterized by the obstruction of blood vessels due to thrombus formation within the deep venous system resulting from a combination of abnormal blood coagulation factors. DVT presents an important clinical challenge because of its high morbidity, disability, and mortality rates [1]. With risk factors becoming increasingly prevalent, the incidence of DVT has shown a marked upward trend in recent years, with reported rates as high as 0.14%–0.16% [2, 3]. Detachment of thrombi in DVT can lead to potential life-threatening complications such as pulmonary embolism (PE) and the development of post-thrombotic syndrome (PTS). Therefore, timely and effective anticoagulation therapy is crucial to achieve complete thrombus dissolution and reduce these risks.
It has been emphasized in the Expert Consensus on the Endovascular Treatment for Deep Venous Post-Thrombotic Syndrome of Lower Extremity (2023) that, in addition to prioritizing therapeutic efficacy, other factors such as safety, timeliness, and the chronic nature of the condition must be taken into consideration in the management of DVT [4]. The commonly used thrombolytic therapies in clinical practice include systemic thrombolysis, deep venous thrombolysis, and catheter-directed thrombolysis (CDT) [5, 6]. Systemic thrombolytic therapy has been shown to be less effective than CDT in reducing lower extremity swelling and thrombus burden, and it carries a greater risk of complications and a higher incidence of PTS [7]. Dorsalis pedis vein thrombolysis (DPVT) offers an effective alternative, especially when CDT is contraindicated or unsuccessful. DPVT is associated with a lower risk of bleeding and is relatively easy to perform [8,9,10]. The theoretical basis of DPVT lies in leveraging the connections between the deep and superficial veins; by blocking the superficial veins, thrombolytic agents administered via the dorsalis pedis vein can be directed to the deep vein thrombosis site, thereby enhancing drug delivery to the target site and improving thrombolytic efficacy.
The selection of an appropriate and effective method to block the blood flow of superficial veins is critical to ensuring accurate and sufficient delivery of thrombolytic agents into the deep venous system, thereby optimizing treatment outcomes. Studies have shown that favorable thrombolytic effects can be achieved by using limb pressure bands to obstruct superficial venous blood flow at various locations in the lower limbs [11,12,13]. However, current protocols typically focus on occluding a single superficial venous vein in the lower leg.
In this study, the aim was to investigate the clinical impact of different superficial venous blood flow blocking regimens in the management of lower extremity DVT, as detailed below.
Sample and methods
Study participants
Sources and grouping of medical records
A total of 42 DVT patients diagnosed with DVT and treated at the Second Affiliated Hospital of Nantong University, Cina, were selected for the study. Participants were divided into two groups: the control group that consisted of 20 patients admitted between January 2023 and August 2023, and the experimental group comprising 22 patients admitted between September 2023 and March 2024.
Inclusion criteria
Participants who fulfilled the following criteria were included in the study: (1) age < 75 years; (2) disease duration of ≤ 28 days; (3) presence of unilateral limb swelling, with a diagnosis of DVT confirmed by digital subtraction angiography (DSA) in accordance with the criteria set forth by the 4th Academic Conference of the Peripheral Vascular Disease Professional Committee of the Chinese Association of Integrative Medicine in October 1995 [14]; (4) treatment with DPVT drugs for a duration of 7–10 days [15], with a minimum follow-up period of 3 months; and (5) written informed consent obtained from all patients for their participation in this study.
Exclusion criteria
Patients with the following conditions were excluded from the study: (1) a history of gastrointestinal bleeding, cerebrovascular hemorrhage, and/or surgery within the past three months; (2) acute or chronic inflammation, skin damage, or allergic reactions affecting the affected limb; (3) coagulation disorders; (4) refractory hypertension (blood pressure > 180/100 mmHg) [16].
Sample size calculation
The aim of this randomized controlled study was to analyze the impact of two distinct balloon pressure band compression regimens on the efficacy of thrombolysis and lower limb blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pedis vein. Sample size estimation was performed using a formula comparing sample means, with μα and μβ representing the values corresponding to a test significance level (α) of 0.05 and a type II error probability (β) of 0.2, yielding μα = 1.960 and μβ = 0.842. The difference in venous thrombus clearance rate was denoted by δ, with previous research [12] indicating a mean difference of 13 before and after intervention. Accordingly, δ was set to 13, and the estimated standard deviation (σ) was 14.1. Based on the formula: \(N={\left[\frac{2({\mu }_{\alpha }+{\mu }_{\beta })\sigma }{\delta }\right]}^{2}\), the required minimum sample size was calculated as 36. Accounting for an anticipated loss to follow-up rate of 15%, the final sample size required was 42 cases.
The study was approved by the Hospital Ethics Committee.
Research methods
Instruments and equipment
1) A specialized sphygmomanometer for thrombolysis (model XJ-B, Jiangsu Yuanyan Medical Equipment Co., Ltd.) with a cuff length of 70 cm, balloon length of 40 cm, and a balloon width of 7.5 cm. 2) A color Doppler ultrasonic detector (Mindray DC-26, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, Guangdong). 3) A computerized infusion pump (model AJ5808, Shanghai Angel Electronic Equipment Co., Ltd.). 4) a reusable vena cava filter (466-F210AF, Cordis [Shanghai] Medical Devices Co., Ltd.).
Low-dose thrombolytic therapy
In both patient groups, indwelling needles were inserted into the superficial dorsalis pedis vein, and a computerized infusion pump was used to continuously administer a low-dose thrombolytic drug regimen. The thrombolytic solution consisted of 100 ml of 0.9% sodium chloride solution mixed with 200,000 U/d of urokinase per day, delivered at a flow rate of 50 ml/h. In addition to thrombolytic therapy, all patients received a subcutaneous injection of nadroparin (Nasaichang, 4100 U every 12 h, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.) as an anticoagulant. Coagulation parameters were monitored daily throughout the intravenous thrombolytic therapy.
Thrombolytic therapy was discontinued under the following conditions: (1) resolution of limb swelling and pain, with venography confirming complete thrombus dissolution, restored blood flow, and unobstructed venous lumen; (2) occurrence of treatment-related complications such as venous inflammation or bleeding; (3) no significant improvement in symptoms such as swelling and pain of the affected limb or no change in intravenous thrombosis on angiography after five consecutive days of treatment; (4) fibrinogen levels dropping to < 1.0 g/L [17, 18].
Methods of blocking superficial venous blood flow
The blood flow of superficial veins of patients in both groups was obstructed using a specialized thrombolysis sphygmomanometer. The occlusion pressure was adjusted to achieve complete disappearance of superficial vein imaging via Digital Subtraction Angiography (DSA) while ensuring complete visualization of deep veins (Figs. 1 and 2). Since each individual’s veins are distinct, the required pressures are also different, making the approach personalized.
-
(1)
Control group: Prior to thrombolysis, the lower edge of the cuff of the special sphygmomanometer for thrombolysis was placed 15 cm above the highest bony landmark of the medial malleolus, and the cuff was wrapped around the limb, maintaining a space sufficient to accommodate one finger. The rotational compression protocol was as follows: after initiation of thrombolysis, alternating cycles of inflation and deflation were performed for 15 min, followed by a 15-min pause, continuously repeated until the completion of the thrombolytic therapy.
-
(2)
Experimental group: Before initiating superficial venous thrombolysis therapy, a specialized thrombolysis sphygmomanometer was used to apply compression alternatively above the ankle and below the knee. The procedure involved positioning and applying pressure above the ankle as per the same parameters used in the control group. Additionally, the upper edge of the pressure band below the knee was placed 10 cm below the midpoint of the patella, and the cuff was wrapped around the limb, ensuring a one-finger space. The rotational compression protocol involved inflating the pressure band above the ankle for 15 min, followed by relaxing the pressure. Immediately after, the pressure band below the knee was inflated for 15 min, then relaxed. This cycle of alternating compression was repeated until the conclusion of the thrombotic treatment.
Quality control
(1) Preparation of testing instruments: The same model of infusion pump, specialized thrombolysis sphygmomanometer, and color Doppler ultrasonic detector were used in all tests. The performance of all instruments and equipment was verified to be optimal before use. (2) Data collection stage: The intraoperative procedures for all patients were consistently performed by the same group of doctors and catheter room nurses. Data collection during procedures was carried out by a single designated nurse from the catheter room. The nursing staff of the ward underwent standardized training from physicians on the correct use of the thrombolysis sphygmomanometer and compression protocols to ensure uniformity in nursing procedures and techniques. Measurements of venous blood flow velocity were conducted by the same sonographer for all patients. (3) Data verification and entry: Data entry was conducted independently by two staff members and cross-verified to ensure the accuracy and integrity of the data entered.
Evaluation procedure
-
(1)
Limb circumference difference and detumescence rate: The patient was positioned supine, and the attending nurse placed the upper edge of a measuring tape 10 cm below the midpoint of the patella every day. The measuring tape was wrapped around the leg in a complete circle, and the circumference of the leg was measured. The difference in limb circumference was defined as the difference between the circumference of the affected limb and the circumference of the healthy limb. The limb detumescence rate was calculated as follows:
$$\text{Limb detumescence rate }= (\text{Difference in limb circumference before thrombolysis }-\text{ Difference in limb circumference after thrombolysis}) /\text{ Difference in limb circumference before thrombolysis }\times 100{\%}.$$ -
(2)
Marder score and limb venous patency rate: The Marder score, a widely accepted measure proposed by Professor Marder in 1977, was used to quantify the extent of intravascular thromboembolism in patients with DVT [19]. Each patient underwent a minimum of two evaluations: the first was during venography at the time of admission, and the second was upon review of venography before removal of the thrombolytic catheter. This score was determined by two experienced interventional physicians (with over five years of experience), who evaluated images uploaded to the hospital’s Picture Archiving and Communication System (PACS) [19].
The venous vascular patency rate was calculated as follows [20]:
$$\text{Venous vascular patency rate }= (\text{Marder score before thrombolysis }-\text{ Marder score after thrombolysis}) /\text{ Marder score before thrombolysis }\times 100{\%}.$$ -
(3)
Venous blood flow velocity of lower extremities: Blood flow measurements of the femoral and popliteal veins were conducted using the Mindray DC-26 color Doppler ultrasound detector with a 5–12 MHz probe. The femoral vein, located in the groin, is positioned obliquely medial to the femoral artery, while the popliteal vein is located in the popliteal fossa and runs parallel to the popliteal artery. After identifying the measurement site, markings were made for consistency across repeated assessments. Blood flow velocities in the femoral and popliteal veins were recorded before thrombolysis (baseline) and at 30 min, 45 min, and 60 min post-thrombolysis.
Statistical analysis
SPSS 22.0 statistical software was used for data analysis. Measurement data conforming to a normal distribution were represented using the mean ± standard deviation (\(\overline{x }\) ± s). An independent samples t-test or analysis of variance (ANOVA) was used for comparison between groups, while the paired t-test was used for within-group comparisons of pre- and post-intervention. Categorical data were represented as the number of cases and percentages (%), with comparisons made using the x2 test. For repeatedly measured data, repeated measures ANOVA was used to evaluate the effects of the intervention across different time points. The difference was considered statistically significant at a P value < 0.05.
Results
Comparison of general data between the two groups of patients
There were no significant differences in basic characteristics such as age, sex, body mass index (BMI), thrombus location, duration of the disease, and comorbidities between patients in the control and experimental groups (P > 0.05) (Table 1).
Comparison of the pre- and post-thrombolysis limb circumference difference and detumescence rates between the two groups of patients
The difference in the circumference of the affected limb was compared before and after thrombolysis in both groups. There was no significant difference in the overall circumference difference of the affected limb between the two groups of patients before thrombolysis (P > 0.05). Post-thrombolysis, there was a statistically significant difference in the overall score of circumference difference of the affected limb (P < 0.001) (Table 2). The detumescence rate of the affected limb was significantly higher in the experimental group compared to the control group (P < 0.001) (Table 3).
Comparison of the pre- and post-thrombolysis Marder score and venous patency rates of the affected limb between the two groups of patients
Analysis of the Marder score and venous patency rates of the affected limb in the two groups of patients revealed no significant differences in these two parameters between the two groups of patients before thrombolytic therapy (P > 0.05). Post-thrombolysis, there were significant differences between the groups, with both the Marder score and venous patency rate improving significantly in the experimental group compared to the control group (P < 0.001) (Tables 4 and 5).
Comparison of the post-thrombolysis blood flow velocity of the femoral and popliteal veins between the two groups of patients
Post-thrombolysis blood flow velocities of the femoral vein of the affected limb at 30, 45, and 60 min were all significantly faster in the experimental group than those in the control group (all P < 0.05). Similarly, the blood flow velocities of the popliteal vein of the affected limb at 30 and 60 min after thrombolysis were all significantly higher in the experimental group than those in the control group (all P < 0.05). However, there was no statistically significant difference in the popliteal vein blood flow velocity of the affected limb at 45 min post-thrombolysis between the two groups (P > 0.05) (Tables 6 and 7).
Discussion
The rotational inflation compression regimen of the balloon pressure band at two sites improved the thrombolytic effect in patients undergoing anterograde thrombolysis for the lower limb via the superficial dorsalis pedis vein
The key to thrombolytic therapy is the prompt and effective restoration of blood flow while preserving normal valve function. Therefore, the choice of appropriate interventional methods and drug administration routes is crucial [21]. Continuous infusion of low-dose thrombolytic agents through an indwelling needle in the superficial dorsalis pedis vein is one of the effective methods for the treatment of DVT in the lower extremities [22]. The vascular architecture of the lower leg features multiple communicating branches between the deep and superficial veins, particularly concentrated in the lower extremities. The connecting branches between the medial and lateral malleolus regions are especially vital, followed by Boyd’s vein [23]. The presence of these abundant perforating veins, which link deep vessels such as the iliac and femoral veins located in the deep fascia with the more superficial network located in the superficial fascia, supports efficient drug distribution from the superficial administration site to deeper thrombosis locations [23].
Yan et al. [12] demonstrated that a rotational inflation-deflation approach wherein limb pressure bands were inflated for 15 min at specific sites (15 cm above the medial malleolus’ bony mark) and then deflated had better outcomes in terms of limb detumescence, thrombus clearance, and patient comfort compared to traditional localized tourniquet applications. Using the anatomical basis of communicating branches in the lower legs, this research team noted that optimal deep vein perfusion occurs when the superficial venous flow is selectively blocked through rotational sphygmomanometer compression with the cuff placed 10 cm below the lower edge of the patella and 15 cm above the proximal end of the medial malleolus joint. This approach ensures a higher concentration of thrombolytic drugs at the thrombotic site, enhancing the thrombolytic effect.
In the current study, to optimize compression efficacy, balloon pressure band settings were established based on DSA findings, confirming that superficial vein imaging disappears while deep vein development is maximized. This pressure range, tailored to avoid patient discomfort, yielded significant improvements, as evidenced by lower circumference differences and Marder scores of the affected limb in the experimental group compared to the control group, alongside higher detumescence rates and improved venous patency in the affected limb (P < 0.05).
The rotational inflation compression regimen of the balloon pressure band at two sites improved the blood flow velocity index of the affected limb in patients undergoing anterograde thrombolysis through the superficial dorsalis pedis vein
In this study, patients in the experimental group were treated with the rotational inflation compression regimen of the balloon pressure band at two sites, involving rotational inflation of a pressure band for durations of 30, 45, and 60 min. The results revealed significantly increased blood flow velocities of the femoral vein of the affected limb compared to the control group, highlighting the efficacy of the pressure band compression regimen in improving lower limb venous blood flow, mirroring the principles underpinning pneumatic therapeutic devices for lower limbs. Although the intervals in this regimen were longer, the blood flow velocity of the lower limbs was observed to be enhanced, thereby preventing the formation of fresh venous thrombi.
Another finding in this study was that the popliteal vein blood flow velocity in the affected limb among patients in the experimental group significantly increased with applying rotational inflation and compression for 30 and 60 min at two sites than pre-thrombolysis levels, and the difference was statistically significant when compared with the control group (all P < 0.05). However, at the 45-min mark, the popliteal vein blood flow velocity in the affected limb was increased in both groups of patients compared to pre-thrombolysis levels, but the difference between the experimental and the control groups was not significant (all P > 0.05). This may be attributable to the specific timing of the compression regimen: at 30 and 60 min, the compression below the knee had just concluded, thereby exerting a proximal influence on the popliteal vein. Conversely, at 45 min, compression was localized above the ankle, likely placing the popliteal vein outside its immediate range of influence.
The study findings suggest that the superior thrombolytic effect observed in the experimental group may be closely linked to increased blood flow velocity during drug administration via the superficial dorsalis pedis vein. By accelerating blood flow, this regimen improves drug delivery to the thrombus site, enhancing the interaction between the drug and the thrombus and achieving a better thrombolytic effect.
Conclusion
In conclusion, blocking the blood flow of the superficial veins of the lower extremities with a balloon pressure band during intraoperative venography is recommended while accurately recording the blocking pressure value for use in compression during subsequent thrombolysis therapy. For continuous low-dose anterograde thrombolysis via an infusion pump through the superficial dorsalis pedis vein, rotational use of balloon pressure bands at 10 cm below the lower edge of the patella and 15 cm above the proximal end of the medial malleolus proved effective in this study. This approach improved blood flow velocity in the lower extremities and yielded better thrombolytic outcomes. However, as a single-center study, the findings have certain inherent limitations and may lack broad authority. Future research, including multi-center investigations with expanded sample sizes, is needed to validate these findings.
Data availability
The datasets generated and/or analysed during the current study are not publicly available but are available from the corresponding author (Li Sun) on reasonable request.
Abbreviations
- DVT:
-
Deep vein thrombosis
- PE:
-
Pulmonary embolism
- PTS:
-
Post-thrombosis syndrome
- CDT:
-
Catheter directed thrombolysis
- DPVT:
-
Dorsalis Pedis Vein Thrombosis
- PACS:
-
Picture archiving and communication system
- DSA:
-
Digital Subtraction Angiography
References
Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060–73. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30 PMID: 27375038.
Shin JM, Hong SJ, Choi KH, Shin SI, Lee DK, Lee SS, Lee BH. Low relative muscle volume: Correlation with prevalence of venous thromboembolism following total knee arthroplasty. PLoS ONE. 2019;14(3):e0210800.
Yang K, Fei C, Wang PF, et al. Analysis of risk factors for postoperative deep vein thrombosis in patients with knee joint fractures. Orthopedics. 2020;11(03):223–8.
Ye KC, Yin MY. Expert consensus on endovascular treatment of deep vein thrombosis syndrome in the lower limbs. J Vasc Endovasc Surg. 2023;9(07):769–76+787.
Kim KA, Choi SY, Kim R. Endovascular treatment for lower extremity deep vein thrombosis: an overview. Korean J Radiol. 2021;22(6):931–43. https://doiorg.publicaciones.saludcastillayleon.es/10.3348/kjr.2020.0675. Epub 2021 Feb 2. PMID: 33660456; PMCID: PMC8154777.
Goldhaber SZ, Magnuson EA, Chinnakondepalli KM, Cohen DJ, Vedantham S. Catheter-directed thrombolysis for deep vein thrombosis: 2021 update. Vasc Med. 2021;26(6):662–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/1358863X211042930. Epub 2021 Oct 4. PMID: 34606385; PMCID: PMC9009765.
Ruihao L, et al. Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: a systematic review and meta-analysis. Thromb Res. 2020;196:340–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.thromres.2020.09.014.
Gil-Díaz A, et al. Diagnosis and treatment of deep vein thrombosis of the lower and upper limbs. 2024 recommendations of the venous thromboembolism group of the Spanish Society of Internal Medicine. Rev Clin Esp. 2024;224(5):300–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.rceng.2024.04.004.
Chu YX, Qin F, Zhang L, et al. Thrombolysis treatment of acute deep vein thrombosis in the lower limbs through different approaches of catheterization. Chin J Gen Surg. 2017;32(3):228–31.
Chen GP, Shi WY, He X, et al. Feasibility of continuous, catheter-directed thrombolysis using low-dose urokinase in combination with low molecular-weight heparin for acute iliofemoral venous thrombosis in patients at risk of bleeding. Exp Ther Med. 2017;13(2):751–8.
White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(90231):4I – 8.
Li Y, Ge JP, Yin YY, et al. Comparison of the application effects of three concurrent thrombolysis methods through superficial dorsal vein of the foot in the treatment of lower limb DVT. Modern Nurs. 2020;26(26):3629–33.
Zeng Y, Mei HY, Liu J, et al. Clinical efficacy of catheter thrombolysis combined with pressure thrombolysis via dorsalis pedis artery and superficial vein of the affected limb for the treatment of deep vein thrombosis in the lower limbs. China Modern Med. 2020;27(22):59–61+65.
Mazzolai L, et al. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function. Eur J Prev Cardiol. 2022;29(8):1248–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/eurjpc/zwab088.
Chen GP, Gu JP, He X, et al. The safety and clinical efficacy of long-term direct thrombolysis with low-dose urokinase via catheter for the treatment of acute iliofemoral vein thrombosis. Chin J Radiol. 2012;46(12):1119–25.
Chinese Medical Association Interventional Physician Branch,Interventional Professional Committee of the Radiology Branch of the Chinese Medical Association, China Venous Intervention Alliance. Expert consensus on interventional treatment standards for lower limb deep venous thrombosis (2nd Edition). Chin Med J. 2018;98(23):1813–21.
Popuri RK, Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2011;31(3):479–84.
Hirsh J, Ginsberg JS, Chan N, et al. Mandatory con-trast-enhanced venography to detect deep-vein thrombo-sis(DVT)in studies of DVT prophylaxis:upsides anddownsides. Thromb Haemost. 2014;111(1):10–3.
Mewissen MW, Seabrook GR, et al. Catheter-directed thrombolysis for lowerextremity deep venous thrombosis:report of a national multicenter registry. Radiology. 1999;211(1):39–49.
Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 1995;21(4):635–45.
Shi WY, Wang LW, Wang SJ, et al. Combined direct and indirect CT venography (combined CTV) in detecting lower extremity deep vein thrombosis. Medicine (Baltimore). 2016;95(11):e3010.
Gong M, He X, Song J, Zhao B, Shi W, Chen G, Gu J. Catheter-directed thrombolysis with a continuous infusion of low-dose alteplase for subacute proximal venous thrombosis: efficacy and safety compared to urokinase. Clin Appl Thromb Hemost. 2018;24(8):1333–9.
Black CM. Anatomy and physiology of the lower-extremity deep and superficial veins. Tech Vasc Interv Radiol. 2024;17(2):68–73.
Acknowledgements
Not applicable.
Funding
1. Command Project of Nantong Municipal Health Commission in 2022(QN2022021);
2. Nantong Natural Science Foundation and Social Livelihood Science and Technology Project in 2023(MSZ2023208).
Author information
Authors and Affiliations
Contributions
Conception and design of the research: Baihong Cui, Li Sun Acquisition of data: Zhiyan Cao, Jia Zhao Analysis and interpretation of the data: Haiyan Gu, Jianan Zhou Statistical analysis: Baihong Cui, Zhiyan Cao Obtaining financing: Baihong Cui, Haiyan Gu, Jianan Zhou Writing of the manuscript: Li Sun, Haiyan Gu Critical revision of the manuscript for intellectual content: Zhiyan Cao, Jia Zhao All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was conducted in accordance with the declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Affiliated Hospital 2 of Nantong University (2024KT572). A written informed consent was obtained from all participants.
Consent for publication
Consent for publication was obtained from every individual whose data are included in this manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Cui, B., Cao, Z., Gu, H. et al. Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pedis vein. Thrombosis J 23, 13 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12959-025-00697-w
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12959-025-00697-w